tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics (DE:BX20)
:BX20
Germany Market

Bioxcel Therapeutics (BX20) Technical Analysis

Compare
9 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
1Neutral
11Bearish
Technical Analysis Consensus
Buy
5Bullish
1Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Bioxcel Therapeutics’s (BX20) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Bioxcel Therapeutics is a Sell.
Bioxcel Therapeutics’s (BX20) 20-Day exponential moving average is 2.56, while Bioxcel Therapeutics’s (BX20) share price is €2.56, making it a Sell.
Bioxcel Therapeutics’s (BX20) 50-Day exponential moving average is 2.84, while Bioxcel Therapeutics’s (BX20) share price is €2.56, making it a Sell.

Bioxcel Therapeutics (BX20) Pivot Points

May 30, 2025, 04:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.51
2.54
2.55
2.57
2.58
2.61
2.62
Fibonacci
2.54
2.55
2.56
2.57
2.59
2.59
2.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bioxcel Therapeutics (BX20) Moving Averages

May 30, 2025, 04:47 PM
Period
Simple
Exponential
MA5
2.56Buy
2.56Sell
MA10
2.56Sell
2.56Sell
MA20
2.56Buy
2.56Sell
MA50
2.56Buy
2.84Sell
MA100
3.68Sell
4.12Sell
MA200
6.46Sell
7.83Sell
Bioxcel Therapeutics’s (BX20) 10-Day exponential moving average is 2.56, while Bioxcel Therapeutics’s (BX20) share price is €2.56, making it a Sell.
Bioxcel Therapeutics’s (BX20) 100-Day exponential moving average is 4.12, while Bioxcel Therapeutics’s (BX20) share price is €2.56, making it a Sell.
Bioxcel Therapeutics’s (BX20) stock price is €2.56 and Bioxcel Therapeutics’s (BX20) 50-day simple moving average is 2.56, creating a Buy signal.
Bioxcel Therapeutics’s (BX20) stock price is €2.56 and Bioxcel Therapeutics’s (BX20) 100-day simple moving average is 3.68, creating a Sell signal.
Bioxcel Therapeutics’s (BX20) stock price is €2.56 and Bioxcel Therapeutics’s (BX20) 200-day simple moving average is 6.46, creating a Sell signal.

Bioxcel Therapeutics (BX20) Technical Indicators

May 30, 2025, 04:47 PM
Name
Value
Implied Action
RSI (14)
26.44
Buy
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
-0.02
Sell
ADX (14)
30.94
Neutral
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
0.04
-
Ultimate Oscillator
<0.01
Sell
ROC
0.00
-
Bioxcel Therapeutics’s (BX20) Relative Strength Index (RSI) is 26.44, creating a Buy signal.
Bioxcel Therapeutics’s (BX20) Trend Strength Indicator (ADX) is 30.94, creating a Neutral signal.

FAQ

Is BX20 a Buy, Hold, or Sell?
Based on BX20’s technical indicators, BX20 is a Sell.
    What is BX20’s RSI (14)?
    BX20’s RSI (14) is 26.44, which suggests BX20 is a Buy.
      What is BX20’s MACD?
      BX20’s MACD is -0.02, which suggests BX20 is a Sell.
        What is BX20’s 5-day moving average?
        BX20’s 5-day moving average is 2.56, which suggests BX20 is a Buy.
          What is BX20’s 20-day moving average?
          BX20 20-day moving average is 2.56, which suggests BX20 is a Buy.
            What is BX20’s 50-day moving average?
            BX20’s 50-day moving average is 2.56, which suggests BX20 is a Buy.
              What is BX20’s 200-day moving average?
              BX20’s 200-day moving average is 6.46, which suggests BX20 is a Sell.
                What is BX20’s Williams % R (14)?
                BX20’s Williams % R (14) is -100.00, which suggests BX20 is a Buy.
                  What is BX20’s CCI (14)?
                  Currently, no data Available
                  What is the share price of Bioxcel Therapeutics?
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis